Ratings
0
Nobody has rated this yet. Be the first!
Works
4
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection
